RECURRENT HIGH GRADE B-CELL LYMPHOMA WITH MYC AND BCL2 REARRANGEMENTS
Clinical trials for RECURRENT HIGH GRADE B-CELL LYMPHOMA WITH MYC AND BCL2 REARRANGEMENTS explained in plain language.
Never miss a new study
Get alerted when new RECURRENT HIGH GRADE B-CELL LYMPHOMA WITH MYC AND BCL2 REARRANGEMENTS trials appear
Sign up with your email to follow new studies for RECURRENT HIGH GRADE B-CELL LYMPHOMA WITH MYC AND BCL2 REARRANGEMENTS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New bridge to a cancer cure: drug combo aims to get more patients to Life-Saving CAR-T
Disease control Recruiting nowThis study is testing a two-drug combination (golcadomide and rituximab) as a 'bridging therapy' for adults with aggressive B-cell lymphoma that has returned or not responded to prior treatment. The goal is to control the cancer and improve patients' health so they can qualify fo…
Matched conditions: RECURRENT HIGH GRADE B-CELL LYMPHOMA WITH MYC AND BCL2 REARRANGEMENTS
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New immune therapy trial aims to control Tough-to-Treat blood cancer
Disease control Recruiting nowThis study is testing whether adding a new immune-boosting drug called epcoritamab to standard chemotherapy and a stem cell transplant can better control aggressive large B-cell lymphoma that has returned or not responded to prior treatment. It will involve about 25 adults whose …
Matched conditions: RECURRENT HIGH GRADE B-CELL LYMPHOMA WITH MYC AND BCL2 REARRANGEMENTS
Phase: PHASE2 • Sponsor: Joseph Tuscano • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC